Skip to main content
HairCited

[Treatment of alopecia areata totalis and maligna with Solvezink (author's transl)].

F Wolowa
Other Zeitschrift fur Hautkrankheiten 1982 2 인용
PubMed
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D7080589'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

연구 유형
Clinical Trial (non-randomized/observational, retrospective)
표본 크기
284
중재
[Treatment of alopecia areata totalis and maligna with Solvezink (author's transl)]. Solvezink (zinc sulfate oral solution); dosage individualized
대조군
Placebo
효과 방향
Positive
비뚤림 위험
High

Abstract

Treatment with Solvezink has been performed in 284 patients: 42 with alopecia areata, 106 with alopecia totalis (preserved axillar and pubic air as well as eyelashes and brows) and 136 with alopecia maligna. The duration of the treatment including maintenance therapy was up to 6 years. In patients with alopecia areata a state without relapse of 1 to 4 years was achieved in 42,8% of cases, in alopecia totalis and maligna a maintenance therapy was necessary to ensure a permanent regrowth of the hair. When applied correctly, Solvezink was well tolerated. The dosages and the treatment intervals of the treatment should be adjusted individually.

요약

Treatment with Solvezink was well tolerated and in patients with alopecia areata a state without relapse of 1 to 4 years was achieved in 42,8% of cases, in alopECia totalis and maligna a maintenance therapy was necessary to ensure a permanent regrowth of the hair.

Used In Evidence Reviews

Similar Papers